MNMarceline Djuidje Ngounoue

Marceline Djuidje Ngounoue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marceline Djuidje Ngounoue has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hepatitis B Vaccine Response and Immunological Markers in Cameroonian Children Aged 0-15 Years: A Cross-Sectional Study at Cité Verte District Hospital, Yaoundé

    by Marceline Djuidje Ngounoue, Axel Cyriaque Ambassa, Mbayam Mbaimou Frédéric, Christian Tague, Celine Nkenfou

    Background: Childhood hepatitis B vaccination remains one of the most effective strategies for reducing the global burden of chronic hepatitis B virus (HBV) infection and its complications. Hepatitis B is a potentially fatal liver condition representing a major public health concern, with acute and chronic forms that can lead to liver failure, cirrhosis, and cancer. The likelihood of chronic HBV infection is inversely related to age at infection, with newborns having a 90-95% risk compared to 5-10% in adults. In Cameroon, regional prevalence rates range from 7-27%. However, limited research has examined how Cameroonian children respond to HBV vaccination, and no systematic measures exist to confirm vaccine efficacy post-administration.Methods: We evaluated HBV vaccine response in regularly vaccinated children aged 0-15 years at Cité Verte District Hospital, Yaoundé. Blood samples were collected from volunteer participants for laboratory analysis. HBV surface antigen (HBsAg) detection was performed using immunochromatographic methods, while anti-HBs antibody levels and interleukin-2 (IL-2) concentrations were determined using indirect ELISA and sandwich ELISA techniques, respectively.Findings: Seventy-three children were enrolled (mean age: 2.1±0.83 years), comprising 42 females (57.5%) and 31 males (42.5%). HBsAg prevalence was 5.5%. Anti-HBs antibody levels were significantly higher in children aged 0-5 years (75.28±23.46 IU/L) compared to those aged 11-15 years (11.54±9.34 IU/L) (p=0.027). HBV-negative children showed significantly elevated antibody levels compared to HBV-positive children (39.30±32.53 vs 8.5±4.5 IU/L, respectively; p=0.001). IL-2 concentrations were higher in HBV-negative children, with a strong positive correlation (r=0.81) observed between anti-HBs antibody levels and IL-2 concentrations.Interpretation: Following complete vaccination schedules, immune system cells produce interleukin-2 capable of stimulating specific antibody production upon subsequent antigen exposure, demonstrating effective vaccine-induced immunity in this population.

  • Open Access

    Increased HIV and other sexually transmitted infections in two health facilities in Northern Cameroon between 2021 and 2022

    by Patrice Djataou, Marceline D. Ngounoue, Georges Nguefack-Tsague, Jean de Dieu Anoubissi, Joséphine J.K. Kadji, Tiga A. Aline, Elise Elong, Moussa Djaouda, Alexis Ndjolo, Celine N. Nkenfou

    Background: Human immunodeficiency viruses (HIV) and acquired immunodeficiency syndrome (AIDS) remain a global public health problem. Other sexually transmitted infections (STIs) are aggravating factors. Aim: This study aimed to assess the prevalence and identify new cases of HIV and STIs, as well as their associated risk factors. Setting: Political insecurity in the northern regions of Cameroon has led to population displacement, weakening an already fragile health system. Methods: A cohort of 684 consenting participants from the north and far north were enrolled in 2021 and followed up in 2022. Socio-demographic variables and risk behaviours were collected. Anti-HIV Ab, hepatitis B surface antigen, Treponema pallidum haemagglutination tests were performed. The data were analysed using Epi Info 7.5.2. The associations between variables were evaluated using the Chi-square test with a 95% confidence interval. Results: The new cases of HIV rate and overall prevalence were 1.63% (95% confidence interval [CI]: 0.83% – 2.41%) and 3.8% (95% CI: 2.01% – 3.97%), respectively. New HIV cases increased from 0.27% (2017, Demographic and Health Survey [DHS]) to 1.63%. The prevalence of syphilis and hepatitis B was 1.03% (95% CI: 0.98% – 1.09%) and 4.56% (95% CI: 4.51% – 4.66%), respectively. Factors associated with HIV included religion (p = 0.027), unprotected sex (p = 0.006), sex with a sex worker (p = 0.00009), and co-infection with syphilis and hepatitis B (p = 0.033). New HIV infections may also be associated with population displacement. Conclusion: HIV infection, syphilis and hepatitis B are on the rise in the Northern Cameroon. Contribution: Future HIV prevention strategies should consider population displacement and HIV-associated infections such as hepatitis B and syphilis in order to secure achievements in HIV programme and further curb the burden of these infections in the country.


  • Open Access

    Assessment of the quality of vaccination data in the centre region health districts of Cameroon: protocol for cross-sectional descriptive study with multivariate logistic regression model (Preprint)

    by Marceline Djuidje Ngounoue, Jules Elong, Yanne Emmanuel Ntsobe, Eric Ekorong, Marie Andre Ngo Lipoga, Georges Nguefack-Tsague

    UNSTRUCTURED The Immunization Agenda 2030 strategy is guided by four core principles. People-centered: the strategy is tailored to the specific needs, breaking down barriers; Country-owned: progress is initiated locally, with countries setting context-specific targets; Partnership-based: partners coordinate efforts and involve sectors beyond immunization; Data-guided: high-quality data shapes decision-making at all levels. Cameroon has a national vaccination programme, the expanded programme on immunisation (EPI) to protect its population, especially children, against vaccine-preventable diseases (VPDs). The programme includes key vaccines for polio, measles, diphtheria, pertussis, tetanus, and hepatitis B, and aims to improve access and utilization, particularly in remote areas. Challenges such as incomplete recording, inadequate infrastructures notably poor connectivity, data integrity issues (Inaccuracies, duplications, and reporting errors ), and capacity constraints might lead to poor data quality leading to missed opportunities. Obviously, data play a crucial role in driving informed decision-making and effective implementation of immunization programmes. The present study, thus aims to evaluate the quality of vaccination data in the Yaoundé and Health districts, Centre region of Cameroon. The WHO data self-quality assessment (DSQ) tool will be used to assess especially the data timeliness, accuracy, and completeness as proceeded by the vaccination staff in 2023-2024. Vaccination staff practices will be observed, and a few policymakers will also be interviewed to gain insights into the effectiveness, coverage, and challenges of the vaccination programme in Cameroon. This study is expected to yield outcomes such as assessing the current state of EPI data quality, identifying factors influencing data quality, formulating recommendations to enhance data quality, preparing a comprehensive report, disseminating findings to stakeholders, contributing to existing literature, and ultimately enhancing vaccination data quality in the Centre region, Cameroon.

  • Open Access

    Trend of new cases of Human Immunodeficiency Virus infections in two health facilities in the Northern Cameroon between 2021-2022

    by Patrice Djataou, Marceline Ngounoue Djuidje, Georges Nguefack-Tsague, Jean de Dieu Anoubissi, Joel Kadji Kameni, Aline Tiga, Elise Elong, Moussa Djaouda, Alexis Ndjolo, Céline Nguefeu Nkenfou

    HIV/AIDS continues to be a global public health problem. Studies of the incidence and prevalence of HIV and other sexually transmitted infections (STIs) that may contribute to or aggravate its acquisition remain an effective means of prevention. In recent years, terrorist groups have established themselves in the northern regions of Cameroon. This insecurity has led to a large influx of refugees with no information about their HIV and STI status. Given this above mentioned situation, this study aimed to assess the incidence and prevalence of HIV and STI and their associated risk factors in order to adjust strategies to monitor the epidemic. A cohort of 684 consenting participants from the North and Far North were enrolled in the study in 2021 and followed up in 2022 to measure the incidence and prevalence of HIV and to assess some associated risk factors. Each participant was administered a pretested questionnaire to collect sociodemographic variables and risk behaviors. Anti-HIV Ab, HBsAg (Hepatitis B Surface Antigen), TPHA ( Treponema Pallidum Hemagglutination Assay) tests were performed. The data were compiled using EPI Info 7.5.2 for epidemiological analyses. The association between co-infections of HIV, Hepatitis, and syphilis and HIV incidence was evaluated using the Chi-2 test. The HIV incidence and overall prevalence were 1.63% (163/10,000 population) and 3.8%, respectively. The HIV incidence increased from 0.27% in 2017 (DHS) to 1.63% in the North and Far North regions as found in our study. The incidences of syphilis and hepatitis B were 1.03% and 4.56%, respectively. Factors associated with HIV acquisition included religion (Muslims being more infected, P<0.03), unprotected sex with a new partner (P<0.007), having a sex worker as a partner (P<0.0001), and co-infection with syphilis and hepatitis B (P<0.05). The findings also link increased HIV incidence to insecurity and population displacement. In HIV prevention strategies, it is important to consider the security and political stability context as well as HIV-associated infections such as hepatitis B and syphilis.